风湿病学中的过度诊断与过度治疗:需要保持谨慎
本文为观点文章,讨论风湿病学中过度诊断与过度治疗的问题。作者审视了现代风湿病学的六个范式:早期诊断、强化治疗、缓解、预后与风险分层、循证风湿病学和精准医学,认为尽管这些范式带来巨大进步,但均存在过度诊断与过度治疗的内在风险,因此需要保持谨慎。
要点
- 过度诊断指筛查发现的惰性癌症,本不会导致明显健康问题,却引起不必要的医疗、焦虑和费用。
- 风湿病学中过度诊断与过度治疗鲜有讨论但可能普遍存在。
- 早期诊断、强化治疗、缓解、预后与风险分层、循证风湿病学和精准医学六个范式均存在过度诊断与过度治疗的内在风险。
核心结论
- 尽管现代风湿病学的六个范式带来巨大进步,但均存在过度诊断与过度治疗的内在风险,因此需要保持谨慎。
研究设计与样本
- 观点文章,讨论风湿病学中过度诊断与过度治疗的问题。
主要发现
- 过度诊断由癌症筛查专家提出,指筛查发现的惰性癌症本不会导致明显健康问题。
- 过度诊断导致不必要的医疗(过度治疗)、焦虑和费用。
- 风湿病学中过度诊断与过度治疗鲜有讨论但可能普遍存在。
- 作者讨论了现代风湿病学的六个范式:早期诊断、强化治疗、缓解、预后与风险分层、循证风湿病学和精准医学。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Overdiagnosis is a term coined by experts in cancer screening to point to indolent cancers detected by screening that would have never led to manifest health problems. Overdiagnosis leads to unnecessary medical care (overtreatment), anxiety and cost. In rheumatology overdiagnosis and overtreatment are hardly discussed but likely present. This viewpoint examines how our prevailing views on the management of inflammatory rheumatic diseases may relate to overdiagnosis and overtreatment. Six paradigms of modern rheumatology will be discussed: early diagnosis, intensive treatment, remission, prognosis and risk stratification, evidence-based rheumatology, and precision medicine. It is concluded that, in spite of the enormous progress that they have brought, all paradigms bear the intrinsic dangers of overdiagnosis and overtreatment. So a little caution is in order.
引用
- Landewé RBM. Overdiagnosis and overtreatment in rheumatology: a little caution is in order. Ann Rheum Dis. 2018. PMID: 29973350. doi:10.1136/annrheumdis-2018-213700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。